Back to the future: so what will fibrinolytic therapy offer your patients with myocardial infarction?
作者信息
Mitchell J R
出版信息
Br Med J (Clin Res Ed). 1986 Apr 12;292(6526):973-8. doi: 10.1136/bmj.292.6526.973.
Abstract
摘要
相似文献
1
Back to the future: so what will fibrinolytic therapy offer your patients with myocardial infarction?
Br Med J (Clin Res Ed). 1986 Apr 12;292(6526):973-8. doi: 10.1136/bmj.292.6526.973.
2
Thrombolytic therapy for acute myocardial infarction--round 2.
Lancet. 1988 Mar 12;1(8585):565-7.
3
Thrombolytic treatment in acute myocardial infarction.
Semin Thromb Hemost. 1987 Apr;13(2):186-200. doi: 10.1055/s-2007-1003492.
4
Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (2).
N Engl J Med. 1984 Sep 20;311(12):770-6. doi: 10.1056/NEJM198409203111205.
5
Coronary recanalization in acute myocardial infarction: immediate results and potential risks.
Eur Heart J. 1982 Oct;3(5):404-15. doi: 10.1093/oxfordjournals.eurheartj.a061326.
6
Thrombolysis for evolving myocardial infarction. Health and Public Policy Committee, American College of Physicians.
Ann Intern Med. 1985 Sep;103(3):463-9.
7
Thrombolytic therapy in patients with acute myocardial infarction.
Circulation. 1985 Apr;71(4):627-31. doi: 10.1161/01.cir.71.4.627.
8
An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
Prog Hemost Thromb. 1984;7:325-56.
9
Direct intracoronary thrombolysis: treatment "a la mode". An alternative: the intravenous approach.
Acta Cardiol. 1983;38(5):401-4.
10
引用本文的文献
1
Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Drugs. 1987;33 Suppl 3:117-23. doi: 10.2165/00003495-198700333-00019.
本文引用的文献
1
Fibrinolysis and fibrinolytic activity in man.
Physiol Rev. 1959 Apr;39(2):343-82. doi: 10.1152/physrev.1959.39.2.343.
2
Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction.
N Engl J Med. 1981 Oct 1;305(14):777-82. doi: 10.1056/NEJM198110013051401.
3
Intravenous short-term infusion of streptokinase in acute myocardial infarction.
Circulation. 1983 Mar;67(3):536-48. doi: 10.1161/01.cir.67.3.536.
4
Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
J Pharmacol Exp Ther. 1984 Oct;231(1):146-52.
5
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
N Engl J Med. 1984 Mar 8;310(10):609-13. doi: 10.1056/NEJM198403083101001.
6
Thrombosis: a molecular approach to therapy.
Nature. 1981 Apr 9;290(5806):445-6. doi: 10.1038/290445a0.
7
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
Circulation. 1984 Dec;70(6):1012-7. doi: 10.1161/01.cir.70.6.1012.
8
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
Circulation. 1984 Oct;70(4):606-18. doi: 10.1161/01.cir.70.4.606.
9
Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.
N Engl J Med. 1983 Dec 15;309(24):1477-82. doi: 10.1056/NEJM198312153092402.
10
Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
Circulation. 1983 Nov;68(5):1051-61. doi: 10.1161/01.cir.68.5.1051.
Zotero 插件